MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Nocturnal stridor in multiple system atrophy: video-polysomnography and clinical features

    H. Ryu, J. Paek, S. You, M. Kim, Y. Kim, J. Kim, K. Kim, S. Lee, S. Chung (Daegu, Republic of Korea)

    Objective: We aim to study video-polysomnography (VPSG) and clinical features in patients with MSA. First, we investigate whether VPSG findings differ depending on the presence…
  • 2019 International Congress

    Early stage Parkinson’s disease patients with GBA mutation have more severe motor symptoms and difficult to differentiate in routine clinical practice

    S. Abe, K. Komatsu, H. Satoi, H. Saiki, Y. Oka (Osaka, Japan)

    Objective: The objective of this study is to compare clinical features of early stage of Parkinson’s disease (PD) between with and without positive glucocerebrosidase (GBA)…
  • 2019 International Congress

    [18F]THK-5351 PET Imaging in Progressive Supranuclear Palsy Concomitant with Cerebellar Ataxia in Early-stage: Clinicopathological Observations

    Y. Saitoh, K. Komatsu, E. Imabayashi, A. Moriya, H. Matsuda, Y. Saito, Y. Takahashi (Tokyo, Japan)

    Objective: To describe two cases of progressive supranuclear palsy (PSP) concomitant with cerebellar ataxia in early stage who underwent [18F]THK-5351 PET imaging and to investigate…
  • 2019 International Congress

    Evaluation of Constipation in Patients with Parkinson’s Disease and its Correction

    M. Salokhiddinov, D. Akramova (Tashkent, Uzbekistan)

    Objective: To evaluate the possible causes of constipation, and to find clear methods to correct the disorder. Background: Constipation is a common problem in Parkinson's…
  • 2019 International Congress

    Evaluation of Clinical Peculiarities of Violations of Vertical Vision in Patients with Parkinson’s Disease

    M. Salokhiddinov, D. Akramova (Tashkent, Uzbekistan)

    Objective: To study vertical oculomotor reflexes(VOR) and the state of the functional system "eyelid" in patients with Parkinson's disease. Background: Parkinson's disease (PD) is a common…
  • 2019 International Congress

    Amylin and insulin in Parkinson’s disease patients: a clinical and metabolic study

    A. Sánchez-Gómez, M. Fernández, G. Alcarraz, R. Fernández, M. Ezquerra, A. Cámara, A. Novials, E. Muñoz, F. Valldeoriola, Y. Compta, MJ. Martí (Barcelona, Spain)

    Objective: To assess the possible connection between PD and glucose metabolism (GM) by analyzing the levels of biomarkers of GM in patients with PD. Background:…
  • 2019 International Congress

    Stereopsis as a Visual Biomarker for Parkinson’s Disease

    T. Sang, J. Fatehi, E. Mostofi, B. Zheng, F. Ba (Edmonton, AB, Canada)

    Objective: 1): To assess Parkinson’s disease (PD) patients’ stereopsis function using better and more physiologically meaningful tools; 2): To reveal specific eye behaviors of stereoacuity…
  • 2019 International Congress

    An atypical and interesting feature of Parkinson´s disease

    B. Santos, M. Spitz (Rio de Janeiro, Brazil)

    Objective: To describe the symptoms of three PD patients who exhibited marked facial asymmetry. We also briefly review the literature regarding hemihypomimia in PD and…
  • 2019 International Congress

    Awareness of Levodopa/Carbidopa spacing with meals in patients of Idiopathic Parkinson’s disease – Insights from an Indian Parkinson’s Registry

    N. Sawal, K. Shukla (Chandigarh, India)

    Objective: Food interferes with gastrointestinal absorption of levodopa which requires spacing with meals. Study evaluated how many patient were spacing  levodopa correctly, its effect on…
  • 2019 International Congress

    Nrf2 pathway in patients with Parkinson’s disease

    T. Schirinzi, S. Petrillo, G. Di Lazzaro, N. Mercuri, E. Bertini, F. Piemonte, A. Pisani (Rome, Italy)

    Objective: To demonstrate the activation of Nuclear factor erythroid-2-related factor 2 (Nrf2) pathway in PD patients. Background: Experimental data indicated the critical involvement of Nrf2…
  • « Previous Page
  • 1
  • …
  • 1297
  • 1298
  • 1299
  • 1300
  • 1301
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley